NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)

Typically moves ±5.53% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE
search

NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a 11-report earnings history dating back to Feb 28, 2024. Its average absolute post-earnings move is ±5.53%, and 81.8% of those reactions were positive. Its largest post-earnings gain was +13.65% (Nov 06, 2024) and its largest decline was -3.87% (Aug 07, 2024). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How NAMS moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

11

Avg Abs. Movement

±5.53%

Positive %

81.8%

Negative %

18.2%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 05, 2026 ☽ POST +0.95% —
May 07, 2026 ☀ PRE +12.4% open_in_new
Feb 18, 2026 ☀ PRE +1.47% open_in_new
Nov 05, 2025 ☀ PRE +4.21% open_in_new
event

Earnings Count

11

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.53%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 22 →
22
Funds holding
$380397486
Total value held
Buying
16 added · 6 reduced
Janus Henderson Group Plc
$72253603 NEW BUY
Goldman Sachs Group Inc
$52933164 -19.75%
Ameriprise Financial Inc
$42482886 NEW BUY
Jpmorgan Chase & Co
$38373185 +28.13%
Blackrock, Inc.
$36050487 +19.98%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
4 20261002 open_in_new SEC.gov
8-K 20260929 open_in_new SEC.gov
SCHEDULE 13D/A 20260922 open_in_new SEC.gov
8-K 20260921 open_in_new SEC.gov
4 20260915 open_in_new SEC.gov
4 20260909 open_in_new SEC.gov
4 20260903 open_in_new SEC.gov
144/A 20260825 open_in_new SEC.gov
4 20260825 open_in_new SEC.gov
144 20260824 open_in_new SEC.gov

Frequently asked about NAMS earnings

When does NewAmsterdam Pharma Company N.V. Ordinary Shares report earnings next? expand_more

NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does NAMS stock move after earnings? expand_more

Over 11 reports, NAMS has moved an average of ±5.53% the session after earnings, closing higher 81.8% of the time.

What was NAMS's biggest post-earnings move? expand_more

NAMS's largest post-earnings gain on record was +13.65% on Nov 06, 2024, and its largest decline was -3.87% on Aug 07, 2024.

Where can I find NewAmsterdam Pharma Company N.V. Ordinary Shares's SEC filings? expand_more

All of NewAmsterdam Pharma Company N.V. Ordinary Shares's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers

Reporting around the same time